Hexarelin 6mg Vial

Hexarelin 6 mg vial is a lyophilized synthetic hexapeptide classified as a growth hormone–releasing peptide (GHRP). It acts as a potent growth hormone secretagogue by binding to the growth hormone secretagogue receptor (GHS-R1a), a G-protein–coupled receptor expressed in the hypothalamus and pituitary gland. Activation of this receptor stimulates pulsatile growth hormone (GH) release and downstream increases in insulin-like growth factor-1 (IGF-1), supporting metabolic regulation, tissue repair, and body composition changes . Compared to other GHRPs, Hexarelin is considered highly potent and stable, producing strong GH pulses even at relatively low doses. Research also suggests that Hexarelin may exert effects beyond endocrine stimulation, as GHS-R receptors are distributed in peripheral tissues including the cardiovascular system . Notably, Hexarelin has demonstrated cardioprotective properties independent of GH release. Studies indicate it can interact with the CD36 receptor in cardiac tissue, potentially reducing damage from ischemia and improving heart function . A typical 6 mg vial contains sterile freeze-dried powder intended for reconstitution in controlled research settings. While promising, research also notes possible elevations in cortisol and prolactin, along with receptor desensitization over time, emphasizing the importance of monitored use in investigational applications. https://pubmed.ncbi.nlm.nih.gov/15361691/ https://pmc.ncbi.nlm.nih.gov/articles/PMC4178518/